Articles
-
-
Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer’s disease
-
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration
-
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
-
Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity
Aims and scope
Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Collections
Glial and Vascular Contributions to Neurodegenerative Diseases
See Molecular Neurodegeneration's ongoing Collection on Glial and Vascular Contributions to Neurodegenerative Diseases.
ALS: Challenges and New Advances
See Molecular Neurodegeneration's ongoing Collection on ALS: Challenges and New Advances.
News from Alzforum
Follow
Annual Journal Metrics
-
2022 Citation Impact
15.1 - 2-year Impact Factor
15.8 - 5-year Impact Factor
3.022 - SNIP (Source Normalized Impact per Paper)
5.158 - SJR (SCImago Journal Rank)2023 Speed
30 days submission to first editorial decision for all manuscripts (Average)
143 days submission to accept (Average)2023 Usage
1,584,169 downloads
2,567 Altmetric mentions
Contact the Managing Editorial Team
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline